Comparative efficacy of mono- and combined therapy for idiopathic short stature with delayed puberty
Background. Growth hormone therapy for idiopathic short stature (ISS) is a subject of debate, because of the heterogeneous endocrine profile in these children. The purpose of this work was to evaluate the effectiveness of mono- (testosterone enanthate) and combined therapy (testosterone enanthate a...
Main Authors: | G.N. Rakhimova, K.N. Gilyazetdinov |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2018-04-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/136420 |
Similar Items
-
Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency
by: Minji Im, et al.
Published: (2017-06-01) -
Novel genetic cause of idiopathic short stature
by: Min Jae Kang
Published: (2017-09-01) -
Effect of Growth Hormone on Final Height in Children with Idiopathic Short Stature: A UAE, Eastern Region Experience
by: Shireen Mreish, et al.
Published: (2017-11-01) -
Genetic causes of isolated short stature
by: Gabriela A. Vasques, et al. -
Effect of -202 A/C IGFBP-3 polymorphisms on growth responses in children with idiopathic short stature
by: Hye Ree Kang, et al.
Published: (2020-03-01)